AR014211A1 - Derivados de tiazol, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen, compuestos intermediarios y su uso para lamanufactura de un medicamento - Google Patents
Derivados de tiazol, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen, compuestos intermediarios y su uso para lamanufactura de un medicamentoInfo
- Publication number
- AR014211A1 AR014211A1 ARP980106722A ARP980106722A AR014211A1 AR 014211 A1 AR014211 A1 AR 014211A1 AR P980106722 A ARP980106722 A AR P980106722A AR P980106722 A ARP980106722 A AR P980106722A AR 014211 A1 AR014211 A1 AR 014211A1
- Authority
- AR
- Argentina
- Prior art keywords
- zero
- alkyl
- formula
- pharmaceutical preparations
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Derivados de tiazol de formula (I), en los que R1 es formula (II); R2 es formula (III), en los que Het es un sistema de anillo heterocíclico de 5 a 8miembros, que está sustituido con R9 y en el que puede estar presente un átomo adicional deN, O o S en el anillo, además del átomo de nitrogeno; R3es hidrogeno, alquilo, cicloalquilo, arilo, aralquilo o heteroarilo; R4 es hidrogeno, alquilo, cicloalquilo, arilo o heteroarilo; R5, R6, R7 y R8 soncada uno independientemente hidrogeno,alquilo o cicloalquilo, o R7 y R8 junto con los átomos de nitrogeno a los que están unidos forman un anilloheterocíclico de 5 a 8 miembros que puede estar sustituido con alquilo; R9 es formula (IV); R10 es arilo, aralquilo, heterociclilo o un alfa-aminoácido unidoa través del grupo amino, deaa ison 0 o numeros positivos enteros,de modo que a y b son cada uno independientemente de cero a 4, d escero o 1, siendo f igual a cero cuando d es igual a cero, la suma de c, d y e es >/= 1 y </== 4, f y h son cada unoindependientemente cero o 1, siendo i diferente de cero cuando h = 1, la suma de g, h e i es >/= 2 y </=5; así como sales y éteresde los mismos farmacéuticamente utilizables, que inhiben la union de proteínas adhesivas sobre la superficie de diferentes tipos de células y deeste modo influyen en las interacciones célula-célula y célula-matriz, procedimiento para su preparacion, preparaciones farmacéuticas que loscontienen, compuestos intermediarios ysu uso en forma de preparaciones farmacéuticas para el control o prevencion de neoplasmas, metástasis detumores, osteoporosis, enfermedad de Paget, retinopatía diabética, degeneracion macular, restenosis tras la intervencion vascular, psoriasis,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98100007 | 1998-01-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014211A1 true AR014211A1 (es) | 2001-02-07 |
Family
ID=8231230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106722A AR014211A1 (es) | 1998-01-02 | 1998-12-29 | Derivados de tiazol, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen, compuestos intermediarios y su uso para lamanufactura de un medicamento |
Country Status (29)
Country | Link |
---|---|
US (1) | US6001855A (es) |
JP (1) | JP3154982B2 (es) |
KR (1) | KR100312900B1 (es) |
CN (1) | CN1098849C (es) |
AR (1) | AR014211A1 (es) |
AT (1) | ATE217621T1 (es) |
AU (1) | AU718659B2 (es) |
BR (1) | BR9805750A (es) |
CA (1) | CA2257322C (es) |
CO (1) | CO4990935A1 (es) |
DE (1) | DE69805392T2 (es) |
DK (1) | DK0928793T3 (es) |
ES (1) | ES2176895T3 (es) |
HK (1) | HK1021733A1 (es) |
HR (1) | HRP980644B1 (es) |
HU (1) | HUP9803041A3 (es) |
ID (1) | ID21878A (es) |
IL (1) | IL127784A (es) |
MA (1) | MA26590A1 (es) |
NO (1) | NO312134B1 (es) |
PE (1) | PE20000116A1 (es) |
PL (1) | PL330620A1 (es) |
PT (1) | PT928793E (es) |
RU (1) | RU2166503C2 (es) |
SG (1) | SG72911A1 (es) |
TR (1) | TR199802766A2 (es) |
UY (1) | UY25335A1 (es) |
YU (1) | YU60998A (es) |
ZA (1) | ZA9811923B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4517454B2 (ja) * | 2000-06-01 | 2010-08-04 | 宇部興産株式会社 | 4−(1−フルオロエチル)チアゾール−5−カルボン酸アミド誘導体及び農園芸用の有害生物防除剤 |
US6451821B1 (en) * | 2000-06-09 | 2002-09-17 | Aventis Pharma S.A. | Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase |
US6420566B2 (en) * | 2000-06-09 | 2002-07-16 | Aventis Pharma S.A. | Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof |
WO2017095991A1 (en) * | 2015-12-04 | 2017-06-08 | Janssen Biotech, Inc. | Treatment of retinal degeneration using progenitor cells |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0123741A1 (en) * | 1983-04-26 | 1984-11-07 | Shionogi & Co., Ltd. | 2-Guanidino-4-hydroxymethylthiazole and derivatives thereof |
IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
TW201303B (es) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
NZ318926A (en) * | 1995-08-30 | 1999-04-29 | Searle & Co | Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion |
WO1997026250A1 (en) * | 1996-01-16 | 1997-07-24 | Merck & Co., Inc. | Integrin receptor antagonists |
DE69835430T2 (de) * | 1997-05-30 | 2007-03-08 | Takeda Pharmaceutical Co. Ltd. | Sulfonamidderivate, ihre herstellung und verwendung |
-
1998
- 1998-12-22 US US09/218,200 patent/US6001855A/en not_active Expired - Fee Related
- 1998-12-28 NO NO19986160A patent/NO312134B1/no unknown
- 1998-12-29 PE PE1998001292A patent/PE20000116A1/es not_active Application Discontinuation
- 1998-12-29 YU YU60998A patent/YU60998A/sh unknown
- 1998-12-29 ZA ZA9811923A patent/ZA9811923B/xx unknown
- 1998-12-29 HR HR980644A patent/HRP980644B1/xx not_active IP Right Cessation
- 1998-12-29 IL IL12778498A patent/IL127784A/en not_active IP Right Cessation
- 1998-12-29 AR ARP980106722A patent/AR014211A1/es not_active Application Discontinuation
- 1998-12-30 TR TR1998/02766A patent/TR199802766A2/xx unknown
- 1998-12-30 AU AU96145/98A patent/AU718659B2/en not_active Ceased
- 1998-12-30 CO CO98077474A patent/CO4990935A1/es unknown
- 1998-12-30 AT AT98124819T patent/ATE217621T1/de not_active IP Right Cessation
- 1998-12-30 SG SG1998005979A patent/SG72911A1/en unknown
- 1998-12-30 DK DK98124819T patent/DK0928793T3/da active
- 1998-12-30 DE DE69805392T patent/DE69805392T2/de not_active Expired - Fee Related
- 1998-12-30 ES ES98124819T patent/ES2176895T3/es not_active Expired - Lifetime
- 1998-12-30 KR KR1019980061644A patent/KR100312900B1/ko not_active IP Right Cessation
- 1998-12-30 CA CA002257322A patent/CA2257322C/en not_active Expired - Fee Related
- 1998-12-30 PT PT98124819T patent/PT928793E/pt unknown
- 1998-12-30 HU HU9803041A patent/HUP9803041A3/hu unknown
- 1998-12-30 MA MA25410A patent/MA26590A1/fr unknown
- 1998-12-30 PL PL98330620A patent/PL330620A1/xx not_active Application Discontinuation
- 1998-12-31 CN CN98125981A patent/CN1098849C/zh not_active Expired - Fee Related
- 1998-12-31 UY UY25335A patent/UY25335A1/es not_active IP Right Cessation
- 1998-12-31 BR BR9805750-2A patent/BR9805750A/pt not_active Application Discontinuation
-
1999
- 1999-01-04 ID IDP990002A patent/ID21878A/id unknown
- 1999-01-04 JP JP00020699A patent/JP3154982B2/ja not_active Expired - Fee Related
- 1999-01-05 RU RU99100205/04A patent/RU2166503C2/ru not_active IP Right Cessation
-
2000
- 2000-01-31 HK HK00100585A patent/HK1021733A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR014949A1 (es) | Derivados de tiazol, procedimiento para su preparacion, composicion farmaceutica que los contiene, compuestos intermediarios y su uso para la manufacturade un medicamento | |
GB1058822A (en) | 3-amino-2-hydroxypropoxy heterocyclic derivatives | |
HUP0301857A2 (hu) | 3(5)-Ureido-pirazol-származékok, eljárás elżállításukra alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
DE58908652D1 (de) | Aminoalkylindole, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate. | |
HUP0300846A2 (hu) | Imidazopirimidin- és triazolopirimidin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
AR004516A1 (es) | Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen | |
AR050084A1 (es) | Derivados de bencimidazolona como inhibidores de hsp90 | |
AR017189A1 (es) | Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento | |
AR014211A1 (es) | Derivados de tiazol, procedimiento para su preparacion, preparaciones farmaceuticas que los contienen, compuestos intermediarios y su uso para lamanufactura de un medicamento | |
DK0488897T3 (da) | Guanidinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
ES2071666T3 (es) | Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
DK118287A (da) | Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel | |
AR024222A1 (es) | Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen | |
DK304584D0 (da) | Beta-carbolinderivater, fremgangsmaade til fremstilling heraf samt laegemiddel indeholdende samme | |
AR027578A1 (es) | Derivados de indano | |
ATE44745T1 (de) | Pyrimido(2,1-b)benzothiazolderivate und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen. | |
HUP0104202A2 (hu) | Tiazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények | |
AR003927A1 (es) | Derivados de cefalosporina, preparaciones farmaceuticas que los contienen, un procedimiento para su preparacion y su uso para la manufactura demedicamentos | |
ES2155546T3 (es) | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen. | |
GB1450452A (en) | Derivatives of pyrazolo 3,4-2,3- pyrido 4,5-e- b-benzo-1,5- diazepinones | |
SE7714685L (sv) | Forfarande for framstellning av nya basiskt substituerade o-propyloximer samt deras anvendning sasom lekemedel | |
HUP0203558A2 (hu) | Helyettesített pirrolok, mint rák kezelésére alkalmas burjánzásellenes vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
GB1307256A (en) | Piperazine derivatives and a process for their preparation | |
DK614989A (da) | Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
KR910007939A (ko) | 헤테로사이클릭 화합물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |